Related Experiment Video
Updated: Jul 26, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Emerging roles of the long non-coding RNA NEAT1 in gynecologic cancers
Maryam Farzaneh1, Mahrokh Abouali Gale Dari2, Amir Anbiyaiee3
1Fertility, Infertility and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Abstract:
Gynecologic cancers are a worldwide problem among women. Recently, molecular targeted therapy opened up an avenue for cancer diagnosis and treatment. Long non-coding RNAs (lncRNAs) are RNA molecules (> 200 nt) that are not translated into protein, and interact with DNA, RNA, and proteins. LncRNAs were found to play pivotal roles in cancer tumorigenesis and progression. Nuclear paraspeckle assembly transcript 1 (NEAT1) is a lncRNA that mediates cell proliferation, migration, and EMT in gynecologic cancers by targeting several miRNAs/mRNA axes. Therefore, NEAT1 may function as a potent biomarker for the prediction and treatment of breast, ovarian, cervical, and endometrial cancers. In this narrative review, we summarized various NEAT1-related signaling pathways that are critical in gynecologic cancers. Long non-coding RNA (lncRNA) by targeting various signaling pathways involved in its target genes can regulate the occurrence of gynecologic cancers.
Insights
Nuclear paraspeckle assembly transcript 1 (NEAT1), a long non-coding RNA (lncRNA), is crucial in gynecologic cancers. NEAT1 shows potential as a biomarker for predicting and treating breast, ovarian, cervical, and endometrial cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gynecologic cancers pose a significant global health challenge for women.
- Long non-coding RNAs (lncRNAs) are emerging as key regulators in cancer development and progression.
- Nuclear paraspeckle assembly transcript 1 (NEAT1) is a lncRNA implicated in various cellular processes relevant to cancer.
Purpose of the Study:
- To review the role of NEAT1 in gynecologic cancers.
- To summarize NEAT1-related signaling pathways critical in gynecologic cancer progression.
- To explore NEAT1 as a potential biomarker for gynecologic cancer diagnosis and treatment.
Main Methods:
- This study is a narrative review.
- Literature search on NEAT1 and gynecologic cancers.
- Analysis of NEAT1's involvement in tumorigenesis and progression via miRNA/mRNA axes.
Main Results:
- NEAT1 mediates cell proliferation, migration, and epithelial-mesenchymal transition (EMT) in gynecologic cancers.
- NEAT1 targets multiple miRNA/mRNA pathways crucial for cancer development.
- NEAT1 is implicated in breast, ovarian, cervical, and endometrial cancers.
Conclusions:
- NEAT1 plays a pivotal role in the tumorigenesis and progression of gynecologic cancers.
- NEAT1 holds promise as a potent biomarker for the prediction and treatment of these cancers.
- Targeting NEAT1-related pathways may offer novel therapeutic strategies for gynecologic malignancies.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
The Nucleolus
MicroRNAs

